0000919574-24-005848.txt : 20241011 0000919574-24-005848.hdr.sgml : 20241011 20241011111950 ACCESSION NUMBER: 0000919574-24-005848 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20241011 DATE AS OF CHANGE: 20241011 EFFECTIVENESS DATE: 20241011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sofinnova BioEquities Enhanced Offshore Fund Ltd. CENTRAL INDEX KEY: 0001949442 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-461677 FILM NUMBER: 241366768 BUSINESS ADDRESS: STREET 1: 94 SOLARIS AVENUE, CAMANA BAY STREET 2: PO BOX 1348 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1108 BUSINESS PHONE: 650-681-8482 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 3, SUITE 150 CITY: MENLO PARK STATE: CA ZIP: 94025 D/A 1 primary_doc.xml X0708 D/A LIVE 0001949442 Sofinnova BioEquities Enhanced Offshore Fund Ltd. 94 SOLARIS AVENUE, CAMANA BAY BOX 1348 GRAND CAYMAN CA CALIFORNIA KY1-1108 650-681-8482 CAYMAN ISLANDS None None Other Cayman Islands Exempted Company true 2022 -- Sofinnova Investments, Inc. 3000 Sand Hill Road BUILDING 3, SUITE 150 Menlo Park CA CALIFORNIA 94025 Executive Officer Promoter Investment Manager Eric Delbridge 3000 Sand Hill Road BUILDING 3, SUITE 150 Menlo Park CA CALIFORNIA 94025 Director Cary Marr Mourant Governance Services (Cayman) Ltd 94 Solaris Ave, Camana Bay, Box 1348 Grand Cayman E9 CAYMAN ISLANDS KY1-1108 Director Paul Stevenson Mourant Governance Services (Cayman) Ltd 94 Solaris Ave, Camana Bay, Box 1348 Grand Cayman E9 CAYMAN ISLANDS KY1-1108 Director Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0000919574-23-005658 2022-10-01 true true true false 100000 Indefinite 226253053 Indefinite false 2 0 true 0 true 0 true The Investment Manager is paid customary management fees and non-affiliated directors are paid customary directors' fees. false Sofinnova BioEquities Enhanced Offshore Fund Ltd. /s/Jim Brody Jim Brody Chief Compliance Officer 2024-10-11